Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 


F&P Healthcare FY earning beat guidance, sees more gains

F&P Healthcare beats 2013 guidance, forecasts boost in 2014 profit; shares gain to 2 ½ year high

By Tina Morrison

May 23 (BusinessDesk) - Fisher & Paykel Healthcare, which makes breathing masks and respirators, expects to beat analyst expectations for 2014 profit as it surpassed its own guidance for 2103 profit today as a result of revenue growth, improved gross margins and operating efficiencies. The shares rose to a two-and-a-half year high.

Profit is likely to be $85 million to $90 million in the year ending March 13, 2014, managing director Michael Daniell said in a statement today. That's more than the $79 million-to-$83 million range expected in a survey of seven analysts by Merlin Consulting.

The stock rose 2.6 percent to $3.11, and has gained 23 percent this year.

F&P Healthcare said 2013 profit rose 20 percent to $77.1 million in the year ended March 31, ahead of its February guidance of about $75 million. The company, which competes with Resmed and Respironics, boosted operating revenue to a record $556.3 million in 2013 on strong demand for its respiratory systems and new masks to treat the condition obstructive sleep apnea.

"We expect our underlying revenue growth to continue to be robust this year, driven by a broad range of new products and applications," Daniell said in the statement. "Constant currency operating margin is expected to increase as a result of growth in higher margin differentiated products, cost reductions and other efficiencies."

The company expects operating revenue of $610 million to $630 million in 2014, Daniell said. The 2014 forecasts are based on the New Zealand dollar trading between 80 US cents and 85 US cents for the remainder of the year as about half its operating revenue is derived in US dollars.

In US dollar terms, sales of respiratory products rose 12 percent to US$245.5 million in 2013 while sales of devices to treat obstructive sleep apnea increased 3.9 percent to US$191.9 million.

F&P Healthcare expects to outlay $40 million in capital expenditure in 2014. That's down from $62 million in 2013 when it spent on new equipment to increase manufacturing capacity, new product tooling, replacement equipment and $33.6 million to complete a third building on its Auckland site.

Making an increased quantity and range of products at its plant in Mexico contributed to an increase in the company's gross margin, Daniell said. The gross margin jumped to 55.3 percent in 2013 from 53.2 percent the year earlier.

Research and development spending increased 9 percent in 2013 and current new projects include masks, flow generators, humidifier systems and respiratory and acute care consumables.

The company spent 6 percent more on selling as it expanded in North America, Europe and the Asia Pacific regions.

The company's diluted earnings per share increased to 13.8 cents in 2013 from 11.7 cents the year earlier. It will pay a final dividend of 7 cents a share on July 5, unchanged from the year earlier.

(BusinessDesk)

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Half Full: Dairy Payouts Steady, Cash Will Be Tight

Industry body DairyNZ is advising farmers to focus on strong cashflow management as they look ahead to the 2015-16 season following Fonterra's half-year results announcement today. More>>

ALSO:

First Union: Cotton On Plans To Use “Tea Break” Law

“The Prime Minister reassured New Zealanders that ‘post the passing of this law, will you all of a sudden find thousands of workers who are denied having a tea break? The answer is absolutely not’... Cotton On is proposing to remove tea and meal breaks for workers in its safety sensitive distribution centre. How long before other major chains try and follow suit?” More>>

ALSO:

Scoop Business: NZ-Korea FTA Signed Amid Spying, Lost Sovereignty Claims

A long-awaited free trade agreement between New Zealand and South Korea has been signed in Seoul by Prime Minister John Key and the Korean president, Park Geun-hye. More>>

ALSO:

PM Visit: NZ And Viet Nam Agree Ambitious Trade Target

New Zealand and Viet Nam have agreed an ambitious target of doubling two-way goods and service trade to around $2.2 billion by 2020, Prime Minister John Key has announced. More>>

ALSO:

Scoop Business: NZ Economy Grows 0.8% In Fourth Quarter

The New Zealand economy expanded in the fourth quarter as tourists drove growth in retailing and accommodation, and property sales increased demand for real estate services. More>>

ALSO:

Scoop Business: RBNZ’s Wheeler Keeps OCR On Hold, No Rate Hikes Ahead

The Reserve Bank has removed the prospect of future interest rate hikes from its forecast horizon as a strong kiwi dollar and cheap oil hold down inflation, and the central bank ponders whether to lower its assessment of where “neutral” interest rates should be. The kiwi dollar gained. More>>

ALSO:

Get More From Scoop

 
 
 
 
 
 
 
 
 
Business
Search Scoop  
 
 
Powered by Vodafone
NZ independent news